Clinical TrialHealthy VolunteersRecruiting

Psychedelic Virtual Reality

This observational trial (n=15) will evaluate a novel Virtual Reality Psychedelic (VRP) called DeepDream using the Meta Quest 3 device.

Target Enrollment
15 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

The primary objective is to determine whether the subjective experience produced by the DeepDream VRP is comparable to a standard dose of psychedelics and to compare DeepDream with other VR modalities designed to mimic psychedelic experiences.

Observational case-crossover design in healthy volunteers (estimated n=15) using the Meta Quest 3 headset; incidence of VRP adverse effects and subjective experience metrics will be assessed.

Study Protocol

Preparation

sessions

Dosing

1 sessions

Integration

sessions

Study Arms & Interventions

DeepDream VRP

experimental

Single-session VR psychedelic simulation delivered via Meta Quest 3 in healthy volunteers; compared to other VR modalities.

Interventions

  • Compound
    via Other• single session

    DeepDream VRP delivered via Meta Quest 3 headset (virtual-reality device).

Participants

Ages
21 – 65
Sexes
Male & Female

Inclusion Criteria

  • Ability to provide informed consent
  • No history or current DSM-V diagnosis

Exclusion Criteria

  • Unstable medical conditions

Study Details

  • Status
    Recruiting
  • Phase
    Phase NA
  • Type
    observational
  • Design
    Non-randomized
  • Target Enrollment15 participants
  • Timeline
    Start: 2024-09-15
    End: 2025-03-31
  • Topic
    Healthy Volunteers

Locations

Yale University School of Medicine — New Haven, Connecticut, United States

Your Library